Skip to main content
Laurus Labs Limited logo

Laurus Labs Limited — Investor Relations & Filings

Ticker · LAURUSLABS ISIN · INE947Q01028 LEI · 335800S8HO8QRYP3VQ26 BSE.NS Manufacturing
Open in API
Filings indexed 705 across all filing types
Latest filing 2023-04-27 Regulatory Filings
Country IN India
Listing BSE.NS LAURUSLABS

About Laurus Labs Limited

https://www.lauruslabs.com/

Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.

Recent filings

Filing Released Lang Actions
Related Party Transactions
Regulatory Filings Classification · 95% confidence The document is a disclosure of Related Party Transactions for the half year ended March 31, 2023, submitted to stock exchanges as per SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It contains detailed tabular data on transactions between the company and its related parties, including subsidiaries, associates, key management personnel, and others. The document is a regulatory compliance filing providing transactional details rather than a full financial report or management discussion. It is not an Annual Report, Interim Report, or Earnings Release. It is also not a report publication announcement or certification. The nature of the document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2023-04-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short letter addressed to stock exchanges informing them about the audio recording of the Full Year and Q4 FY23 Results conference call. It references a previous intimation about the results conference call and provides a web link to the audio recording. The document does not contain any financial data or detailed transcript but is an announcement related to the conference call. Given the short length (1222 characters) and the nature of the content (announcement of audio recording availability), this fits best as a Regulatory Filing (RNS) rather than a full Call Transcript (CT) or Earnings Release (ER).
2023-04-27 English
Book Closure
Regulatory Filings Classification · 95% confidence The document is a notification about the book closure dates for the purpose of the 18th Annual General Meeting (AGM) of Laurus Labs Limited. It specifies the dates when the register of members and share transfer books will be closed and mentions the date and mode of the AGM. There is no financial data, detailed report, or presentation included. The document serves as an announcement related to the AGM, specifically about administrative arrangements (book closure) rather than the AGM materials themselves. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories like AGM Information or Notice of Dividend.
2023-04-27 English
Record Date
Notice of Dividend Amount Classification · 100% confidence The document is a formal communication from the company's Board of Directors announcing the approval of the 2nd interim dividend for the financial year 2022-23. It specifies the dividend amount per share, the record date for eligibility, and the payment date. The document is short (1368 characters) and focuses solely on dividend declaration details without any financial statements or broader financial performance data. This matches the definition of a Notice of Dividend Amount (DIV).
2023-04-27 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release announcing the financial results for the quarter and full year ended March 31, 2023. It contains summarized financial highlights such as revenue, EBITDA, PAT, EPS, and business segment performance. It also includes commentary from the CEO and CFO, business highlights, and dividend announcement. The document is titled 'Press Release' and is addressed to stock exchanges, indicating it is an initial announcement of quarterly and annual financial results. It does not contain detailed financial statements or comprehensive analysis typical of an Interim/Quarterly Report (IR) or Annual Report (10-K). The length (10,527 characters) and content suggest it is more than a brief earnings release but still primarily an earnings announcement. Therefore, the most appropriate classification is Earnings Release (ER).
2023-04-27 English
Investor Presentation
Investor Presentation Classification · 100% confidence The document is titled as an "Investors/Analysts Presentation" and is addressed to stock exchanges (BSE and NSE) with codes indicating a corporate filing. It mentions a presentation on the standalone and consolidated financial results for the quarter and year ended March 31, 2023, and is intended for an investors/analysts call. The content includes detailed financial results, business updates, strategic outlook, and operational highlights. The length is substantial (15,000 characters), and the document is clearly a presentation rather than a formal report like an annual or quarterly report. There is no indication that this is a report publication announcement or a certification. The document fits the definition of an Investor Presentation (IP) as it focuses on financials, strategy, and market position for investors and analysts.
2023-04-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.